Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Mileo, Anna Maria ^a   Miccadei, Stefania ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CELL PROLIFERATION; MODULATION; OXIDATIVE STRESS; STEM CELLS;

ANTI-OXIDANT ACTIVITIES; BIOACTIVE COMPOUNDS; CANCER DEVELOPMENT; CANCER STEM CELLS; CELLULAR GROWTH; GENOME INSTABILITY; THERAPEUTIC STRATEGY; THERAPEUTIC TOOLS;

DISEASES;

POLYPHENOL; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CANCER THERAPY; CELL GROWTH; CELL METABOLISM; CHEMOPROPHYLAXIS; CYTOSTASIS; CYTOTOXICITY; EPIGENETICS; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; NEOPLASMS;

ANIMALS; ANTIOXIDANTS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; POLYPHENOLS; REACTIVE OXYGEN SPECIES;

EID: 84948799646     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6475624     Document Type: Article

References (194)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics, " CA-Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. L. Shu, K.-L. Cheung, T. O. Khor, C. Chen, and A.-N. Kong, "Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis, " Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 483-502, 2010.
3. N. Kontou, T. Psaltopoulou, D. Panagiotakos, M. A. Dimopoulos, and A. Linos, "Themediterranean diet in cancer prevention: A review, " Journal of Medicinal Food, vol. 14, no. 10, pp. 1065-1078, 2011.
4. K.-W. Luo, C.-H. Ko, G. G.-L. Yue et al., "Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice, " Journal of Nutritional Biochemistry, vol. 25, no. 4, pp. 395-403, 2014.
5. T. Norat, D. Aune, D. Chan, and D. Romaguera, "Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention, " Cancer Treatment and Research, vol. 159, pp. 35-50, 2014.
6. A. C. Tan, I. Konczak, D. M.-Y. Sze, and I. Ramzan, "Molecular pathways for cancer chemoprevention by dietary phytochemicals, " Nutrition and Cancer, vol. 63, no. 4, pp. 495-505, 2011.
7. T. Maraldi, "Natural compounds as modulators of NADPH oxidases, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 271602, 10 pages, 2013.
8. C. G. Lee, J. H. Koo, and S. G. Kim, "Phytochemical regulation of Fyn and AMPK signaling circuitry, " Archives of Pharmacal Research, 2015.
9. I. Kalaiselvan, M. Samuthirapandi, A. Govindaraju, D. Sheeja Malar, and P. D. Kasi, "Olive oil and its phenolic compounds (hydroxytyrosol and tyrosol) ameliorated TCDD-induced heptotoxicity in rats via inhibition of oxidative stress and apoptosis, " Pharmaceutical Biology, vol. 8, pp. 1-9, 2015.
10. L. Elbling, R.-M. Weiss, O. Teufelhofer et al., "Green tea extract and (-)-epigallocatechin-3-gallate, themajor tea catechin, exert oxidant but lack antioxidant activities, " The FASEB Journal, vol. 19, no. 7, pp. 807-809, 2005.
11. H. Y. Khan, H. Zubair, M. F. Ullah, A. Ahmad, and S. M. Hadi, "A pro-oxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols, " Current Drug Targets, vol. 13, no. 14, pp. 1738-1749, 2012.
12. H. Y. Khan, H. Zubair, M. Faisal et al., "Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: A mechanism for cancer chemopreventive action, " MolecularNutrition&Food Research, vol. 58, no. 3, pp.437-446, 2014.
13. A. Gupte and R. J. Mumper, "Elevated copper and oxidative stress in cancer cells as a target for cancer treatment, " Cancer Treatment Reviews, vol. 35, no. 1, pp. 32-46, 2009.
14. L. W. Wattenberg, "Chemoprophylaxis of carcinogenesis: A review, " Cancer Research, vol. 26, no. 7, pp. 1520-1526, 1966.
15. P. Kubatka, A. Kapinova, M. Kello et al., "Fruit peel polyphenols demonstrate substantial anti-Tumour effects in the model of breast cancer, " European Journal of Nutrition, 2015.
16. M. Gonźalez-Vallinas, M. Gonźalez-Castejon, A. Rodŕiguez-Casado, and A. R. de Molina, "Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives, " Nutrition Reviews, vol. 71, no. 9, pp. 585-599, 2013.
17. N. Khan and H. Mukhtar, "Dietary agents for prevention and treatment of lung cancer, " Cancer Letters, vol. 359, no. 2, pp. 155-164, 2015.
18. O. O. Olaku, M. O. Ojukwu, F. Z. Zia, and J. D. White, "The role of grape seed extract in the treatment of chemo/radiotherapy induced toxicity: A systematic review of preclinical studies, " Nutrition and Cancer, vol. 67, no. 5, pp. 730-740, 2015.
19. N. Sebastia, A. Montoro, D. Hervas et al., "Curcumin and trans-resveratrol exert cell cycle-dependent radioprotective or radiosensitizing effects as elucidated by the PCC and G2-Assay, " Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 766-767, pp. 49-55, 2014.
20. L. Hayflick, "Human cells and aging, " Scientific American, vol. 218, no. 3, pp. 32-37, 1968.
21. J. J. Marin, M. Vergel, and A. Carnero, "Targeting cancer by inducing senescence, " The Open Enzyme Inhibition Journal, vol. 3, pp. 46-52, 2010.
22. M. Lee and J.-S. Lee, "Exploiting tumor cell senescence in anticancer therapy, " BMB Reports, vol. 47, no. 2, pp. 51-59, 2014.
23. J. A. Ewald, J. A. Desotelle, G. Wilding, and D. F. Jarrard, "Therapy-induced senescence in cancer, " Journal of the National Cancer Institute, vol. 102, no. 20, pp. 1536-1546, 2010.
24. F. Vahid, H. Zand, E. Nosrat-Mirshekarlou, R. Najafi, and A. Hekmatdoost, "The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review, " Gene, vol. 562, no. 1, pp. 8-15, 2015.
25. G. Supic, M. Jagodic, and Z. Magic, "Epigenetics: A new link between nutrition and cancer, " Nutrition and Cancer, vol. 65, no. 6, pp. 781-792, 2013.
26. Y. Li, M. S. Wicha, S. J. Schwartz, and D. Sun, "Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds, " The Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 799-806, 2011.
27. M. Malavolta, L. Costarelli, R. Giacconi et al., "Modulators of cellular senescence: mechanisms, promises, and challenges from in vitro studies with dietary bioactive compounds, " Nutrition Research, vol. 34, no. 12, pp. 1017-1035, 2014.
28. A. M. Mileo, D. Di Venere, C. Abbruzzese et al., "Long term exposure to polyphenols of artichoke (Cynara scolymus L.) exerts induction of senescence driven growth arrest in the MDA-MB231 human breast cancer cell line, " OxidativeMedicine and Cellular Longevity, vol. 2015, Article ID 363827, 11 pages, 2015.
29. V. Sosa, T. Molińe, R. Somoza, R. Paciucci, H. Kondoh, and M. E. LLeonart, "Oxidative stress and cancer: An overview, " Ageing Research Reviews, vol. 12, no. 1, pp. 376-390, 2013.
30. T. Guina, F. Biasi, S. Calfapietra, M. Nano, and G. Poli, "Inflammatory and redox reactions in colorectal carcinogenesis, " Annals of the New York Academy of Sciences, vol. 1340, no. 1, pp. 95-103, 2015.
31. D. Thapa and R. Ghosh, "Chronic inflammatory mediators enhance prostate cancer development and progression, " Biochemical Pharmacology, vol. 94, no. 2, pp. 53-62, 2015.
32. L. Beaugerie, "Management of inflammatory bowel disease patients with a cancer history, " Current Drug Targets, vol. 15, no. 11, pp. 1042-1048, 2014.
33. M. Murata, R. Thanan, N. Ma, and S. Kawanishi, "Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID623019, 11 pages, 2012.
34. J. E. Klaunig, L. M. Kamendulis, and B. A. Hocevar, "Oxidative stress and oxidative damage in carcinogenesis, " Toxicologic Pathology, vol. 38, no. 1, pp. 96-109, 2010.
35. L. Huo, C.-W. Li, T.-H. Huang et al., "Activation of keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells, " American Journal of Translational Research, vol. 6, no. 6, pp. 649-663, 2014.
36. J. Korbecki, I. Baranowska-Bosiacka, I. Gutowska, and D. Chlubek, "The effect of reactive oxygen species on the synthesis of prostanoids fromarachidonic acid, " Journal of Physiology and Pharmacology, vol. 64, no. 4, pp. 409-421, 2013.
37. A. Matsuzawa and H. Ichijo, "Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling, " Biochimica et Biophysica Acta-General Subjects, vol. 1780, no. 11, pp. 1325-1336, 2008.
38. A. Nguyen, A. C. M. Chang, and R. R. Reddel, "Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress, " Oncogene, vol. 28, no. 18, pp. 1982-1992, 2009.
39. E. A. C. Wiemer, "Stressed tumor cell, chemosensitized cancer, " Nature Medicine, vol. 17, no. 12, pp. 1552-1554, 2011.
40. G. Barrera, "Oxidative stress and lipid peroxidation products in cancer progression and therapy, " ISRN Oncology, vol. 2012, Article ID 137289, 21 pages, 2012.
41. C. Gorrini, I. S. Harris, and T.W. Mak, "Modulationof oxidative stress as an anticancer strategy, " Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931-947, 2013.
42. D. Trachootham, W. Lu, M. A. Ogasawara, N. R.-D. Valle, and P. Huang, "Redox regulation of cell survival, " Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343-1374, 2008.
43. A. Sharma, M. Rajappa, A. Saxena, and M. Sharma, "Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation, " British Journal of Biomedical Science, vol. 64, no. 1, pp. 23-27, 2007.
44. D. Ivanova, R. Bakalova, D. Lazarova, V. Gadjeva, and Z. Zhelev, "The impact of reactive oxygen species on anticancer therapeutic strategies, " Advances in Clinical and Experimental Medicine, vol. 22, no. 6, pp. 899-908, 2013.
45. K. I. Block, A. C. Koch, M. N. Mead, P. K. Tothy, R. A. Newman, and C. Gyllenhaal, "Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials, " International Journal of Cancer, vol. 123, no. 6, pp. 1227-1239, 2008.
46. M. A. Russo, L. Sansone, L. Polletta et al., "Sirtuins and resveratrol-derived compounds: A model for understanding the beneficial effects of the Mediterranean diet, " Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 14, no. 4, pp. 300-308, 2014.
47. A. D. Goldberg, C. D. Allis, and E. Bernstein, "Epigenetics: A landscape takes shape, " Cell, vol. 128, no. 4, pp. 635-638, 2007.
48. A. Bird, "Perceptions of epigenetics, " Nature, vol. 447, no. 7143, pp. 396-398, 2007.
49. S. Sarkar, G. Horn, K. Moulton et al., "Cancer development, progression, and therapy: An epigenetic overview, " International Journal of Molecular Sciences, vol. 14, no. 10, pp. 21087-21113, 2013.
50. J. Sandoval and M. Esteller, "Cancer epigenomics: beyond genomics, " Current Opinion in Genetics and Development, vol. 22, no. 1, pp. 50-55, 2012.
51. J. D. Choi and J.-S. Lee, "Interplay between epigenetics and genetics in cancer, " Genomics & Informatics, vol. 11, no. 4, pp. 164-173, 2013.
52. E. Baxter, K. Windloch, F. Gannon, and J. S. Lee, "Epigenetic regulation in cancer progression, " Cell and Bioscience, vol. 4, article 45, 2014.
53. M. Kulis and M. Esteller, "DNA methylation and cancer, " Advances in Genetics, vol. 70, pp. 27-56, 2010.
54. K. D. Hansen, W. Timp, H. C. Bravo et al., "Increased methylation variation in epigenetic domains across cancer types, " Nature Genetics, vol. 43, no. 8, pp. 768-775, 2011.
55. H. Olzscha, S. Sheikh, and N. B. La Thangue, "Deacetylation of chromatin and gene expression regulation: A new target for epigenetic therapy, " Critical Reviews in Oncogenesis, vol. 20, no. 1-2, pp. 1-17, 2015.
56. J. Lopez-Pastrana, Y. Shao, V. Chernaya, H. Wang, and X. Yang, "Epigenetic enzymes are the therapeutic targets for CD4+CD25+/hhFoxp3+ regulatory T cells, " Translational Research, vol. 165, no. 1, pp. 221-240, 2015.
57. P. Mummaneni and S. S. Shord, "Epigenetics and oncology, " Pharmacotherapy, vol. 34, no. 5, pp. 495-505, 2014.
58. B. G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I. M. Adcock, and P. J. Barnes, "Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages, " The Journal of Experimental Medicine, vol. 200, no. 5, pp. 689-695, 2004.
59. C. A. Hamm and F. F. Costa, "Epigenomes as therapeutic targets, " Pharmacology &Therapeutics, vol. 151, pp. 72-86, 2015.
60. A. Link, F. Balaguer, and A. Goel, "Cancer chemoprevention by dietary polyphenols: promising role for epigenetics, " Biochemical Pharmacology, vol. 80, no. 12, pp. 1771-1792, 2010.
61. M. Fantini, M. Benvenuto, L. Masuelli et al., "In Vitro and in Vivo antitumoural effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer Treatment, " International Journal of Molecular Sciences, vol. 16, no. 5, pp. 9236-9282, 2015.
62. B. Halliwell, "Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment, " Drugs and Aging, vol. 18, no. 9, pp. 685-716, 2001.
63. I. Rahman and S. Chung, "Dietary polyphenols, deacetylases and chromatin remodeling in inflammation, " Journal of Nutrigenetics and Nutrigenomics, vol. 3, no. 4-6, pp. 220-230, 2010.
64. P. Yang, X. He, and A. Malhotra, "Epigenetic targets of polyphenols in cancer, " Journal of Environmental Pathology, Toxicology and Oncology, vol. 33, no. 2, pp. 159-165, 2014.
65. C. Gerhauser, "Cancer chemoprevention and nutriepigenetics: state of the art and future challenges, " Topics in Current Chemistry, vol. 329, pp. 73-132, 2013.
66. S. Shankar, D. Kumar, and R. K. Srivastava, "Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition, " Pharmacology and Therapeutics, vol. 138, no. 1, pp. 1-17, 2013.
67. H. Lu, W. Ouyang, and C. Huang, "Inflammation, a key event in cancer development, " Molecular Cancer Research, vol. 4, no. 4, pp. 221-233, 2006.
68. W. V. Berghe, "Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes, " Pharmacological Research, vol. 65, no. 6, pp. 565-576, 2012.
69. S. Biswas and I. Rahman, "Modulation of steroid activity in chronic inflammation: A novel anti-inflammatory role for curcumin, " Molecular Nutrition and Food Research, vol. 52, no. 9, pp. 987-994, 2008.
70. I. Rahman, J. Marwick, and P. Kirkham, "Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-B and pro-inflammatory gene expression, " Biochemical Pharmacology, vol. 68, no. 6, pp. 1255-1267, 2004.
71. V. B. O. Ayissi, A. Ebrahimi, and H. Schluesenner, "Epigenetic effects of natural polyphenols: A focus on SIRT1-mediated mechanisms, " Molecular Nutrition and Food Research, vol. 58, no. 1, pp. 22-32, 2014.
72. R. Rajendran, R. Garva, M. Krstic-Demonacos, and C. Demonacos, "Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription, " Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 368276, 17 pages, 2011.
73. K. Sasaki, M. Neyazaki, K. Shindo, T. Ogawa, and M. Momose, "Quantitative profiling of glucosinolates by LC-MS analysis reveals several cultivars of cabbage and kale as promising sources of sulforaphane, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 903, pp. 171-176, 2012.
74. Y. Zhang, P. Talalay, C.-G. Cho, and G. H. Posner, "A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure, " Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2399-2403, 1992.
75. G. H. Posner, C.-G. Cho, J. V. Green, Y. Zhang, and P. Talalay, "Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes, " Journal of Medicinal Chemistry, vol. 37, no. 1, pp. 170-176, 1994.
76. M. McMahon, K. Itoh, M. Yamamoto et al., "The CapnCollar basic leucine zipper transcription factor NRF2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, " Cancer Research, vol. 61, no. 8, pp. 3299-3307, 2001.
77. I. M. Copple, "The Keap1-NRF2 cells defense pathway-A promising therapeutic target?" Advances in Pharmacology, vol. 63, pp. 43-79, 2012.
78. F. Wang and Y. Shan, "Sulforaphane retards the growth of UMUC-3 xenographs, induces apoptosis, and reduces survivin in athymic mice, " Nutrition Research, vol. 32, no. 5, pp. 374-380, 2012.
79. M. C. Myzak, P. A. Karplus, F.-L. Chung, and R. H. Dashwood, "A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase, " Cancer Research, vol. 64, no. 16, pp. 5767-5774, 2004.
80. M. C. Myzak, W. M. Dashwood, G. A. Orner, E. Ho, and R. H. Dashwood, "Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in min mice, " The FASEB Journal, vol. 20, no. 3, pp. 506-508, 2006.
81. K. L. Cheung and A.-N. Kong, "Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention, " AAPS Journal, vol. 12, no. 1, pp. 87-97, 2010.
82. L. G. Wang, A. Beklemisheva, X. M. Liu, A. C. Ferrari, J. Feng, and J. W. Chiao, "Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer, "Molecular Carcinogenesis, vol. 46, no. 1, pp. 24-31, 2007.
83. L. Das and M. Vinayak, "Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of NRF2 signalling and modulation of inflammation in prevention of cancer, " PLoS ONE, vol. 10, no. 4, Article ID e0124000, 2015.
84. J. Kang, J. Chen, Y. Shi, J. Jia, and Y. Zhang, "Curcumin-induced histone hypoacetylation: The role of reactive oxygen species, " Biochemical Pharmacology, vol. 69, no. 8, pp. 1205-1213, 2005.
85. K. Balasubramanyam, R. A. Varier, M. Altaf et al., "Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription, " The Journal of Biological Chemistry, vol. 279, no. 49, pp. 51163-51171, 2004.
86. H.-L. Liu, Y. Chen, G.-H. Cui, and J.-F. Zhou, "Curcumin, a potent anti-Tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation, " Acta Pharmacologica Sinica, vol. 26, no. 5, pp. 603-609, 2005.
87. J. Yang, Y. Cao, J. Sun, and Y. Zhang, "Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells, " Medical Oncology, vol. 27, no. 4, pp. 1114-1118, 2010.
88. A. Murakami, "Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents, " Archives of Biochemistry and Biophysics, vol. 557, pp. 3-10, 2014.
89. H. Pan, J. Chen, K. Shen et al., "Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice, " PLoS ONE, vol. 10, no. 4, Article ID e0124775, 2015.
90. V. S. Thakur, K. Gupta, and S. Gupta, "Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases, " Carcinogenesis, vol. 33, no. 2, pp. 377-384, 2012.
91. K.-C. Choi, G. J. Myung, Y.-H. Lee et al., "Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBVinduced B lymphocyte transformation via suppression of RelA acetylation, " Cancer Research, vol. 69, no. 2, pp. 583-592, 2009.
92. V. Nandakumar, M. Vaid, and S. K. Katiyar, " (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and 16NK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells, " Carcinogenesis, vol. 32, no. 4, pp. 537-544, 2011.
93. S. Sinha, S. Shukla, S. Khan, T. O. Tollefsbol, and S. M. Meeran, "Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ER-dependent in ER-negative human breast cancer cells, " Molecular and Cellular Endocrinology, vol. 406, pp. 102-114, 2015.
94. M. Z. Fang, Y. Wang, N. Ai et al., "Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines, " Cancer Research, vol. 63, no. 22, pp. 7563-7570, 2003.
95. C. Berner, E. Aumüller, A. Gnauck, M. Nestelberger, A. Just, and A. G. Haslberger, "Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds, " Annals of Nutrition andMetabolism, vol. 57, no. 3-4, pp. 183-189, 2011.
96. K. Kato, N. K. Long, H. Makita et al., "Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells, " British Journal of Cancer, vol. 99, no. 4, pp. 647-654, 2008.
97. Z. Gao, Z. Xu, M.-S. Hung et al., "Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells, " Anticancer Research, vol. 29, no. 6, pp. 2025-2030, 2009.
98. H. Zhou, J. X. Chen, C. S. Yang, M. Yang, Y. Deng, and H. Wang, "Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer, " BMC Genomics, vol. 15, supplement 11, article S3, 2014.
99. W. P. Tsang and T. T. Kwok, "Epigallocatechin gallate upregulation of miR-16 and induction of apoptosis in human cancer cells, " The Journal of Nutritional Biochemistry, vol. 21, no. 2, pp. 140-146, 2010.
100. W. J. Lee and B. T. Zhu, "Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catecholcontaining coffee polyphenols, " Carcinogenesis, vol. 27, no. 2, pp. 269-277, 2006.
101. J. F. Savouret and M. Quesne, "Resveratrol and cancer: A review, " Biomedicine & Pharmacotherapy, vol. 56, no. 2, pp. 84-87, 2002.
102. R. K. Srivastava, T. G. Unterman, and S. Shankar, "FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol, " Molecular and Cellular Biochemistry, vol. 337, no. 1-2, pp. 201-212, 2010.
103. K.-H. Jung, J. H. Lee, C. H. T. Quach et al., "Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1 activation, " Journal of Nuclear Medicine, vol. 54, no. 12, pp. 2161-2167, 2013.
104. A. Malhotra, P. Nair, and D. K. Dhawan, "Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis, " PLoS ONE, vol. 9, no. 4, Article ID e93820, 2014.
105. B. A. Narayanan, N. K. Narayanan, G. G. Re, and D. W. Nixon, "Differential expression of genes induced by resveratrol in LNCaP cells: p53-mediated molecular targets, " International Journal of Cancer, vol. 104, no. 2, pp. 204-212, 2003.
106. E. Tili, J.-J. Michaille, H. Alder et al., "Resveratrol modulates the levels of microRNAs targeting genes encoding tumorsuppressors and effectors of TGF signaling pathway in SW480 cells, " Biochemical Pharmacology, vol. 80, no. 12, pp. 2057-2065, 2010.
107. R.-H. Wang, Y. Zheng, H.-S. Kim et al., "Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated tumorigenesis, " Molecular Cell, vol. 32, no. 1, pp. 11-20, 2008.
108. J. George, M. Singh, A. K. Srivastava et al., "Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53, " PLoS ONE, vol. 6, no. 8, Article ID e23395, 2011.
109. B. Stocco, K. A. Toledo, H. F. Fumagalli et al., "Biotransformed soybean extract induces cell death of estrogen-dependent breast cancer cells bymodulation of apoptotic proteins, " Nutrition and Cancer, vol. 67, no. 4, pp. 612-619, 2015.
110. M. Nadal-Serrano, D. G. Pons, J. Sastre-Serra, M. M. Blanquer-Rossello, P. Roca, and J. Oliver, "Genistein modulates oxidative stress in breast cancer cell lines according to ER/ER ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes, "The International Journal of Biochemistry & Cell Biology, vol. 45, no. 9, pp. 2045-2051, 2013.
111. M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang, "Reversal of hypermethylation and reactivation of 16INK4a, RAR, and MGMT genes by genistein and other isoflavones from soy, " Clinical Cancer Research, vol. 11, part 1, no. 19, pp. 7033-7041, 2005.
112. S. Majid, A. A. Dar, A. E. Ahmad et al., "BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer, " Carcinogenesis, vol. 30, no. 4, pp. 662-670, 2009.
113. S. Majid, A. A. Dar, S. Saini et al., "Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer, " Cancer Research, vol. 70, no. 7, pp. 2809-2818, 2010.
114. L. Gibellini, M. Pinti, M. Nasi et al., "Quercetin and cancer chemoprevention, " Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 591356, 15 pages, 2011.
115. N. Li, C. Sun, B. Zhou et al., "Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer, " PLoSONE, vol. 9, no. 7, Article IDe100314, 2014.
116. R. V. Priyadarsini, G. Vinothini, R. S. Murugan, P. Manikandan, and S. Nagini, "Theflavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors, " Nutrition and Cancer, vol. 63, no. 2, pp. 218-226, 2011.
117. E. N. Simsek and T. Uysal, "In vitro investigation of cytotoxic and apoptotic effects of Cynara L. species in colorectal cancer cells, " Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6791-6795, 2013.
118. S. Miccadei, D. DiVenere, A. Cardinali et al., "Antioxidative and apoptotic properties of polyphenolic extracts fromedible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells, " Nutrition and Cancer, vol. 60, no. 2, pp. 276-283, 2008.
119. A.M. Mileo, D. Di Venere, V. Linsalata, R. Fraioli, and S. Miccadei, "Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell lineMDAMB231, " Journal of Cellular Physiology, vol. 227, no. 9, pp. 3301-3309, 2012.
120. C. J. Cairney, A. E. Bilsland, T. R. J. Evans et al., "Cancer cell senescence: A new frontier in drug development, " Drug Discovery Today, vol. 17, no. 5-6, pp. 269-276, 2012.
121. J. C. Acosta and J. Gil, "Senescence: A new weapon for cancer therapy, " Trends in Cell Biology, vol. 22, no. 4, pp. 211-219, 2012.
122. R. M. Naylor, D. J. Baker, and J. M. van Deursen, "Senescent cells: A novel therapeutic target for aging and age-related diseases, " Clinical Pharmacology & Therapeutics, vol. 93, no. 1, pp. 105-116, 2013.
123. J. Campisi and F. dAdda di Fagagna, "Cellular senescence: when bad things happen to good cells, " Nature ReviewsMolecular Cell Biology, vol. 8, pp. 729-740, 2007.
124. A. L. Fitzgerald, A. A. Osman, T.-X. Xie et al., "Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells, " Cell Death and Disease, vol. 6, no. 3, article e1678, 2015.
125. B.-D. Chang, E. V. Broude, M. Dokmanovic et al., "A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents, " Cancer Research, vol. 59, no. 15, pp. 3761-3767, 1999.
126. L.-G. Larsson, "Oncogene-And tumor suppressor genemediated suppression of cellular senescence, " Seminars in Cancer Biology, vol. 21, no. 6, pp. 367-376, 2011.
127. H. Chandler and G. Peters, "Stressing the cell cycle in senescence and aging, " Current Opinion in Cell Biology, vol. 25, no. 6, pp. 765-771, 2013.
128. L. Lan, J. D. Holland, J. Qi et al., "Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice, " The EMBO Journal, vol. 34, no. 11, pp. 1493-1508, 2015.
129. H. Rayess, M. B. Wang, and E. S. Srivatsan, "Cellular senescence and tumor suppressor gene p16, " International Journal of Cancer, vol. 130, no. 8, pp. 1715-1725, 2012.
130. E. J. Yeo, Y. C. Hwang, C.-M. Kang et al., "Senescence-like changes induced by hydroxyurea in human diploid fibroblasts, " Experimental Gerontology, vol. 35, no. 5, pp. 553-571, 2000.
131. B.-D. Chang, Y. Xuan, E. V. Broude et al., "Role of p53 and p21 (waf1/cip1) in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, " Oncogene, vol. 18, no. 34, pp. 4808-4818, 1999.
132. C. Nardella, J. G. Clohessy, A. Alimonti, and P. P. Pandolfi, "Pro-senescence therapy for cancer treatment, " Nature Reviews Cancer, vol. 11, no. 7, pp. 503-511, 2011.
133. K. Banerjee and M. Mandal, "Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells, " Redox Biology, vol. 5, pp. 153-162, 2015.
134. H. Luo, L. Wang, B. A. Schulte, A. Yang, S. Tang, and G. Y. Wang, "Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells, " International Journal of Oncology, vol. 43, no. 6, pp. 1999-2006, 2013.
135. S. Sin, S. Y. Kim, and S. S. Kim, "Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells, " International Journal ofOncology, vol. 41, no. 5, pp. 1669-1674, 2012.
136. Y.-B. Li, J.-L. Gao, Z.-F. Zhong, P.-M. Hoi, S. M.-Y. Lee, and Y.-T. Wang, "Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways, " Pharmacological Reports, vol. 65, no. 3, pp. 700-709, 2013.
137. H. Luo, A. Yang, B. A. Schulte, M. J. Wargovich, and G.Y. Wang, "Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage, " PLoS ONE, vol. 8, no. 3, Article ID e60065, 2013.
138. Q. Yang, B. Wang, W. Zang et al., "Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner, " PLoS ONE, vol. 8, no. 11, Article ID e70627, 2013.
139. L. L. Zamin, E. C. Filippi-Chiela, P. Dillenburg-Pilla, F. Horn, C. Salbego, and G. Lenz, "Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells, " Cancer Science, vol. 100, no. 9, pp. 1655-1662, 2009.
140. S. G. Piccirillo, B. A. Reynolds, N. Zanetti et al., "Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, " Nature, vol. 444, no. 7120, pp. 761-765, 2006.
141. M. E. Prince, R. Sivanandan, A. Kaczorowski et al., "Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 973-978, 2007.
142. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, "Prospective identification of tumorigenic breast cancer cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983-3988, 2003.
143. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi et al., "Identification and expansion of human colon-cancer-initiating cells, " Nature, vol. 445, no. 7123, pp. 111-115, 2007.
144. C. Li, D. G. Heidt, P. Dalerba et al., "Identification of pancreatic cancer stem cells, " Cancer Research, vol. 67, no. 3, pp. 1030-1037, 2007.
145. C. A. OBrien, A. Pollett, S. Gallinger, and J. E. Dick, "A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, " Nature, vol. 445, no. 7123, pp. 106-110, 2007.
146. T. Schatton, G. F. Murphy, N. Y. Frank et al., "Identification of cells initiating human melanomas, " Nature, vol. 451, no. 7176, pp. 345-349, 2008.
147. Z. F. Yang, D. W. Ho, M. N. Ng et al., "Significance of CD90+ cancer stem cells in human liver cancer, " Cancer Cell, vol. 13, no. 2, pp. 153-166, 2008.
148. B.-B. S. Zhou, H. Zhang, M. Damelin, K.G. Geles, J.C. Grindley, and P. B. Dirks, "Tumour-initiating cells: challenges and opportunities for anticancer drug discovery, " Nature Reviews Drug Discovery, vol. 8, no. 10, pp. 806-823, 2009.
149. M. Diehn, R. W. Cho, and M. F. Clarke, "Therapeutic implications of the cancer stem cell hypothesis, " Seminars in Radiation Oncology, vol. 19, no. 2, pp. 78-86, 2009.
150. L. S. Piao, W. Hur, T.-K. Kim et al., "CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma, " Cancer Letters, vol. 315, no. 2, pp. 129-137, 2012.
151. E. Paldino, V. Tesori, P. Casalbore, A. Gasbarrini, and M. A. Puglisi, "Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?" BioMed Research International, vol. 2014, Article ID 859871, 7 pages, 2014.
152. N. You, L. Zheng, W. Liu, X. Zhong, W. Wang, and J. Li, "Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: A potential therapeutic target of stem cell treatment for hepatocellular carcinoma, " Oncology Reports, vol. 31, no. 4, pp. 1911-1920, 2014.
153. K. Chen, Y.-H. Huang, and J.-L. Chen, "Understanding and targeting cancer stem cells: Therapeutic implications and challenges, " Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 732-740, 2013.
154. P.-P. Liu, J. Liao, Z.-J. Tang et al., "Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway, " Cell Death and Differentiation, vol. 21, no. 1, pp. 124-135, 2014.
155. R. Loureiro, K. A. Mesquita, P. J. Oliveira, and I. Vega-Naredo, "Mitochondria in cancer stem cells: A target for therapy, " Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, vol. 7, no. 2, pp. 102-114, 2013.
156. A. Bhardwaj, S. Arora, V. K. Prajapati, S. Singh, and A. P. Singh, "Cancer stemness-regulating microRNAs: role, mechanisms and therapeutic potential, " Current Drug Targets, vol. 14, no. 10, pp. 1175-1184, 2013.
157. S.W. Crowder, D.A. Balikov, Y. S. Hwang, and H. Sung, "Cancer stem cells under hypoxia as a chemoresistance factor in breast and brain, " Current Pathobiology Reports, vol. 2, no. 1, pp. 33-40, 2014.
158. L. Vera-Ramirez, M. Ramirez-Tortosa, P. Perez-Lopez, S. Granados-Principal, M. Battino, and J. L. Quiles, "Long-Term effects of systemic cancer treatment on DNA oxidative damage: The potential for targeted therapies, " Cancer Letters, vol. 327, no. 1-2, pp. 134-141, 2012.
159. S. Shigdar, Y. Li, S. Bhattacharya et al., "Inflammation and cancer stem cells, " Cancer Letters, vol. 345, no. 2, pp. 271-278, 2014.
160. V. Catalano, A. Turdo, S. Di Franco, F. Dieli, M. Todaro, and G. Stassi, "Tumor and its microenvironment: A synergistic interplay, " Seminars in Cancer Biology, vol. 23, no. 6, pp. 522-532, 2013.
161. G. Zhang, P. Yang, P. Guo et al., "Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer, " Biochimica et BiophysicaActa-Reviews on Cancer, vol. 1836, no. 1, pp. 49-59, 2013.
162. Y. Li, M. S. Wicha, S. J. Schwartz, and D. Sun, "Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds, " Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 799-806, 2011.
163. Y. Zhang, "Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action, " Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 555, no. 1-2, pp. 173-190, 2004.
164. S.V. Singh and K. Singh, "Cancer chemopreventionwith dietary isothiocyanates mature for clinical translational research, " Carcinogenesis, vol. 33, no. 10, pp. 1833-1842, 2012.
165. Y. Li and T. Zhang, "Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts, " Future Oncology, vol. 9, no. 8, pp. 1097-1103, 2013.
166. Y. Li, T. Zhang, H. Korkaya et al., "Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells, " Clinical Cancer Research, vol. 16, no. 9, pp. 2580-2590, 2010.
167. M. Rodova, J. Fu, D. N. Watkins, R. K. Srivastava, and S. Shankar, "Sonic hedgehog signalling inhibition provide opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal, " PLoS ONE, vol. 7, no. 9, Article ID e46083, 2012.
168. S.-H. Li, J. Fu, D. N. Watkins, R. K. Srivastava, and S. Shankar, "Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway, " Molecular and Cellular Biochemistry, vol. 373, no. 1-2, pp. 217-227, 2013.
169. W. Zhou, G. Kallifatidis, B. Baumann et al., "Dietary polyphenol quercetin targets pancreatic cancer stem cells, " International Journal of Oncology, vol. 37, no. 3, pp. 551-561, 2010.
170. R. K. Srivastava, S.-N. Tang, W. Zhu, D. Meeker, and S. Shankar, "Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells, " Frontiers in Bioscience (Elite Edition) , vol. 3, no. 2, pp. 515-528, 2011.
171. M. Messina and L. Hilakivi-Clarke, "Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer, " Nutrition and Cancer, vol. 61, no. 6, pp. 792-798, 2009.
172. M. T. E. Montales, O.M. Rahal, H. Nakatani, T. Matsuda, and R. C. M. Simmen, "Repression of mammary adipogenesis by genistein limits mammosphere formation of human MCF-7 cells, " Journal of Endocrinology, vol. 218, no. 1, pp. 135-149, 2013.
173. Y. Su, K. Shankar, and R. C.M. Simmen, "Early soy exposure via maternal diet regulates rat mammary epithelial differentiation by paracrine signaling from stromal adipocytes, " Journal of Nutrition, vol. 139, no. 5, pp. 945-951, 2009.
174. A. Warri, N. M. Saarinen, S. Makela, and L. Hilakivi-Clarke, "The role of early life genistein exposures in modifying breast cancer risk, " British Journal of Cancer, vol. 98, no. 9, pp. 1485-1493, 2008.
175. M. Ĺopez-Ĺazaro, "TheWarburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?" Anti-Cancer Agents in Medicinal Chemistry, vol. 8, no. 3, pp. 305-312, 2008.
176. R. Palorini, G. Votta, C. Balestrieri et al., "Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS, " Journal of Cellular Biochemistry, vol. 115, no. 2, pp. 368-379, 2014.
177. M. Ristow, "Oxidative metabolism in cancer growth, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 9, no. 4, pp. 339-345, 2006.
178. L. G. Boros, S. Bassilian, S. Lim, and W.-N. P. Lee, "Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: A new mechanism of controlling tumor growth, " Pancreas, vol. 22, no. 1, pp. 1-7, 2001.
179. D. Chen, S. Pamu, Q. Cui, T. H. Chan, and Q. P. Dou, "Novel epigallocatechin gallate (EGCG) analogs activate AMPactivated protein kinase pathway and target cancer stem cells, " Bioorganic and Medicinal Chemistry, vol. 20, no. 9, pp. 3031-3037, 2012.
180. J. A. Menendez, J. Joven, G. Aragones et al., "Xenohormetic and anti-Aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents, " Cell Cycle, vol. 12, no. 4, pp. 555-578, 2013.
181. S. Tanveer, E. Fathi, and F. Guy, "Towards new anticancer strategies by targeting cancer stem cells with phytochemical compounds, " in Cancer Stem Cells-The Cutting Edge, P. S. Shostak, Ed., chapter 23, pp. 431-454, InTech, Rijeka, Croatia, 2011.
182. M.-H. Teiten, S. Eifes, M. Dicato, and M. Diederich, "Curcumin-The paradigm of a multi-Target natural compound with applications in cancer prevention and treatment, " Toxins, vol. 2, no. 1, pp. 128-162, 2010.
183. C.-L. Yang, Y.-G. Ma, Y.-X. Xue, Y.-Y. Liu, H. Xie, and G.-R. Qiu, "Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway, " DNA and Cell Biology, vol. 31, no. 2, pp. 139-150, 2012.
184. K.-K. Mak, A. T. H. Wu, W.-H. Lee et al., "Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-B/microRNA 448 circuit, " Molecular Nutrition & Food Research, vol. 57, no. 7, pp. 1123-1134, 2013.
185. A. R. Khuda-Bukhsh, S. Das, and S. K. Saha, "Molecular approaches toward targeted cancer prevention with some food plants and their products: inflammatory and other signal pathways, " Nutrition and Cancer, vol. 66, no. 2, pp. 194-205, 2014.
186. S. Prasad, K. Phromnoi, V. R. Yadav, M.M. Chaturvedi, and B. B. Aggarwal, "Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer, " PlantaMedica, vol. 76, no. 11, pp. 1044-1063, 2010.
187. A. Salminen, M. Lehtonen, T. Suuronen, K. Kaarniranta, and J. Huuskonen, "Terpenoids: natural inhibitors of NF-B signalling with anti-inflammatory and anticancer potential, " Cellular and Molecular Life Sciences, vol. 65, no. 19, pp. 2979-2999, 2008.
188. D. Lippmann, C. Lehmann, S. Florian et al., "Glucosinolates frompak choi and broccoli induce enzymes and inhibit inflammation and colon cancer differently, " Food and Function, vol. 5, no. 6, pp. 1073-1081, 2014.
189. V. Estrella, T. Chen, M. Lloyd et al., "Acidity generated by the tumor microenvironment drives local invasion, " Cancer Research, vol. 73, no. 5, pp. 1524-1535, 2013.
190. M. F. McCarty and J. Whitaker, "Manipulating tumor acidification as a cancer treatment strategy, " Alternative Medicine Review, vol. 15, no. 3, pp. 264-272, 2010.
191. A. Nebbioso, V. Carafa, R. Benedetti, and L. Altucci, "Trials with epigenetic drugs: An update, "Molecular Oncology, vol. 6, no. 6, pp. 657-682, 2012.
192. J. McLarty, R. L. H. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J. A. Cardelli, "Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro, " Cancer Prevention Research, vol. 2, no. 7, pp. 673-682, 2009.
193. T. D. Shanafelt, T. G. Call, C. S. Zent et al., "Phase 2 trial of daily, oral polyphenon e in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia, " Cancer, vol. 119, no. 2, pp. 363-370, 2013.
194. C. Hanau, D. J. Morŕe, and D. M. Morŕe, "Cancer prevention trial of a synergistic mixture of green tea concentrate plus Capsicum (CAPSOL-T) in a randompopulation of subjects ages 40-84, " Clinical Proteomics, vol. 11, no. 1, article 2, 2014.